"Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation" by Charles H Hennekens

Selected Works of Steven Borzak, MD, FACC

Article

Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation

Clinical investigation (2012)

Charles H Hennekens
Scott Hetzel
Michael Pfeffer
Ricky Schneider
Steven Borzak
Wendy Schneider
Victor Serebruany
David DeMets

Link

Disciplines

Pharmacology and
Medicine and Health Sciences

Publication Date

August 21, 2012

DOI

10.4155/CLI.12.56

Citation Information

Charles H Hennekens, Scott Hetzel, Michael Pfeffer, Ricky Schneider, et al.. "Low-dose enteric-coated aspirin does not inhibit thromboxane B2 and prostaglandin E2: data-derived hypothesis formulation" Clinical investigation Vol. 2 Iss. 7 (2012) p. 747 - 752
Available at: http://works.bepress.com/steven-borzak/32/